Osiris Therapeutics, Inc.

Columbia, MD 21046

Market Performance

NASDAQ: OSIR
Market Cap $172 Million
52 Week High $7.39
52 Week Low $2.67

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $0.0
First Award Date 03/10/94
Most Recent Award Date 06/01/99

Key Personnel

Last Name Name Awards Contact
Young Randell G Young 3
Fink David J. Fink 1
Kadiyala Sudhakar Kadiyala 1

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/99 - 05/31/00

In the context of skeletal tissue repair, Regenerative Medicine (TM) is the local application of adult stem cells to promote reconstruction of tissue defects. The objective of Regenerative Medicine (TM) is to deliver a high density of repair-competent cells to the defect site in a format that optimizes both the initial healing process and the su...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/98 - 02/28/02

The Global Hypothesis for the proposed Phase II program is that Mesenchymal Stem Cells (MSCs) can be applied to models of tendon injury to provide improved and accelerated tissue regeneration in clinically meaningful situations. In Phase II we will explore two aspects of tendon repair in areas of important clin...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/05/97 - 02/28/98

The Global Hypothesis for the proposed Phase II program is that Mesenchymal Stem Cells (MSCs) can be applied to models of tendon injury to provide improved and accelerated tissue regeneration in clinically meaningful situations. In Phase II we will explore two aspects of tendon repair in areas of important clin...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/95 - 03/31/98

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/10/94 - 02/29/96

In the context of skeletal tissue repair, Cell Therapy is the local application of autologous (host-derived) cells to promote reconstruction of tissue defects caused by trauma, disease or surgical procedures. The objective of the Cell Therapy approach is to deliver high densities of repair-competent cells ...